Estimated Glycemic Confidence Interval in Determining the Quality of a Graft after Venous Occlusion of the Pedicle in Rats
by Alexandre Yoiti Aoyagui*, Marcela Fernandes, Sandra Gomes Valente, Celso Kiyoshi Hirakawa, Luis Renato Nakachima, Joao Carlos Belloti, João Baptista Gomes dos Santos, Flávio Faloppa
Universidade Federal de São Paulo (UNIFESP), R. Borges Lagoa, 778 - Vila Clementino, São Paulo - SP, 04038-001, Brazil
*Corresponding author: Alexandre Yoti Aoyagui, Universidade Federal de São Paulo (UNIFESP), R. Borges Lagoa, 778 - Vila Clementino, São Paulo - SP, 04038-001, Brazil.
Received Date: 19 May 2024
Accepted Date: 28 May 2024
Published Date: 30 May 2024
Citation: Aoyagui AY, Fernandes M, Valente SG, Hirakawa CK, Nakachima LR, et al. (2024) Estimated Glycemic Confidence Interval in Determining the Quality of a Graft after Venous Occlusion of the Pedicle in Rats. J Surg 9: 11061 https://doi.org/10.29011/2575-9760.11061
Introduction
Currently, the flaps used to cover complex wounds are subject to failure in the event of occlusion of the vascular pedicle. Fortunately, the flap can be saved if revascularization only briefly occurs [1,2]. For this reason, postoperative monitoring has been highlighted as a key parameter in early identification of these cases. Among these, the parameters that always stood out in the literature were a) color, b) temperature, c) turgor, and d) bleeding scarified edges. However, the time interval between the occurrence of occlusion and clinical signs may delay the diagnosis. In this context, several authors have introduced the evaluation of patchwork complex measures with hand-specific work and costly measures such as Doppler ultrasound of the vascular pedicle [3-5], measurement of tissue oxygenation, intra-arterial or intravenous catheters, microdialysis [6], changes in metabolism [7,8], and evaluation with probes for thermal diffusion [9]. However, another measure that is also studied, and is less complex, is blood serum glucose, the point of interest in this study.
Decreases in glucose serum levels and glycogen storage occur early in the flaps with a good prognosis [10], returning to normal by the seventh day after the procedure. In pathological cases, where there is formation of clots or thrombi, a decrease in flap sugar levels is more pronounced, more frequently observed in congestion situations (venous involvement), and also in ischemia or both [11-13]. Even with the use of anticoagulants, clot formation can occur [14]. Following this line of reasoning, glycemic measures can be used to monitor flaps and decrease rate in blood glucose values would be indicative of occlusive changes in the pedicle [15]. In the literature, there have been statements about flap monitoring using an absolute glycemic measure, which can be hard to rely on because the established relationship values are influenced by systemic glucose concentration, which can vary among individuals. With continuous monitoring, the high cost becomes unfeasible in most of the healthcare centers worldwide. For these reasons, the aim of this study was to establish a confidence limit interval to determine the extent of flap distress, taking into account the glycemic measures by measurement with glucometers available in almost all hospitals, which reduces costs and facilitates the specificity and dissemination of this evaluation, which is important in grafts.
Materials and Methods
This experiment was conducted in the laboratory of Microsurgery of the Hand and Upper Limb Department of Orthopedics and Traumatology of a Surgery reference center in Brazil, approved by the internal ethics committee (972,081,013). For the development of the project we used male Wistar rats of the isogenic strain SHR (N = 20, age = 2.5 months, body weight = 280– 300 g), provided by the Experimental Models Development Center for Medicine and Biology of the Federal University São Paulo (CEDEME–UNIFESP). During the study, the experimental animals were kept in a vivarium, with light/dark cycle (12 h:12 h), temperature of 21 ± 2°C, receiving water and standard rat chow ad libitum.
Anesthesia
The animals were anesthetized by intra-peritoneal injection with xylazine anesthetic solution composed by 1 U/100g and ketamine 1 U/100g.
They were divided into two homogeneous groups. They underwent surgery to establish an inguinal flap where the systemic blood glucose levels were measured (via flow) and at the flap edge.
Groups:
- Exposed: 10 SHRs underwent surgery for inguinal flap dissection, followed by occlusion of the pedicle vein.
- Controls: 10 SHRs underwent surgery for inguinal flap dissection, leaving an intact pedicle.
Surgical Technique
Once anesthetized, the animals were submitted to trichotomy of the abdominal region at the level of the knee, with the group assignment randomly chosen. The antisepsis in incised locations was achieved with 70% alcohol. The rat was placed supine and the legs were fixed to the table plane, with a tape. Based on the femoral artery, an inguinal flap, measuring 3 cm long and 2 cm wide, was drawn parallel to the midline, including the femoral artery inside. Then, the skin was incised, followed by blunt dissection of the planes on the medial side, exposing the femoral artery and its branch to the inguinal flap. After exposure of the pedicle (measuring approximately 2 cm with an outside diameter of the vessel of at most 2 mm), the flap was dissected from the cranial portion to flow, isolating the vascular pedicle. In the group in which the venous occlusion was performed, the vein was dissected at the emergence of the pedicle vessels and connected with Prolene 7-0. The surgical procedure was performed under 25x magnified view through a microscope.
Blood Glucose Measurement
Blood glucose level was measured in a drop of blood, both from the caudal vein of the animal (Figure 2B; through venipuncture needle) and at the flap edge (Figure 2A; through the inguinal flap edge fragment), with the aid of a specific Local device (Accu-Chek active; Roche Pharmaceutical Chemicals S/a) composed of sensitive strips for biochemical determination of glucose (Accu-Chek active glucotrend).
Samples were collected at different times, and the data recorded in a spreadsheet and displayed in graphs, as described below:
- 0 minutes–before connecting the vein;
- 30, 60, 90, and 120 minutes–after connecting the vein.
Statistical Analysis
Statistical analysis was performed using descriptive statistics such as mean, standard deviation, standard error (mean standard deviation), and correlation to the characterization of quantitative variables in the study population. In the tests for comparison of quantitative variables, we initially checked the normality by the Shapiro-Wilk test because the sample size was small. The Shapiro-Wilk test did not reject the hypothesis of normality (p > 0.05), indicating that the data (n = 20) are derived from a normal distribution, and therefore parametric tests can be used.
We used the paired t-test for comparisons between glucose measurements, and we used Student’s t test for comparisons between groups. A more refined analysis was performed using a linear models generalized test with repeated measures in order to check the influence over time, with a comparison of groups as well as checking group-time interactions. The results were expressed as mean, maximum, minimum, standard deviation, IC, risk factor, percentage, absolute values used for each test, and a p value < 0.05 was considered statistically significant.
Results
Experimental Data
Glycemic behavior of the groups was evaluated in three stages, first, as a function of time, comparing the groups (control vs. exposed) to measure the degree of flap distress, and a second analysis between glycemia collection sites (Local vs systemic) to observe the times at which they were correlated. In the final stages, the times that had a positive correlation were used to determine the range of glucose values of the Local test that might indicate the boundaries between healthy tissue and distress, expressed always as the percentage of the glycemic value of the commercial test in reference to the systemic blood glucose measurement.
Parametric Data Evaluation
To establish reliable indices in comparisons, we first established normality of the samples by using the Shapiro-Wilk normality test. Normality was not rejected for the variables investigated, with p > 0.05 (Table 1).
Glycemic Performance Evaluation of the Local Test
We observed that the glycemic index in the exposed group decreased over time, while in the control group it remained stable, characterized by a regular upward curve (Figure 1).
In the group of interest, this reduction was associated with disruption of blood flow as measured by the Local test, which caused a constant reduction in glycemic rates by exposing the tissue to hypoxia. Note that this variation was significant when comparing the exposed and control groups from 30 until 120 minutes (0, p = 0.985; 30 min, p = 0.01; 60 min, p = 0.002; 90 min, p <0.0001; 120 min, p = 0.001) (Table 2,3).
Evaluation of Systemic Glycemic Behavior
On comparing the groups for systemic measurement, there was no significant difference over time (0, p = 0.985; 30 min, p = 0.1; 60 min, p = 0.12; 90 min, p = 0.81; 120 min, p = 0.51) (Table 2,3 and Figure 2).
Correlation Between the Local and Systemic Tests
There was a positive correlation in the exposed group at three stages of evaluation, at time 30 minutes where a weak but positive correlation (r = 0.602) was observed, and at times 60 and 90 minutes, with a positive and strong correlation (r = 843 and r = 782, respectively) (Table 4,5) (Figures 3).
In the control group this correlation was positive only at 60 minutes (r = 664) and 90 minutes (r = 824) (Table 6 and 7) (Figures 3).
Local/Systemic Glucose Ratio
After determining the success of the experimental model, we evaluated the times when the glucose values of the Local test correlated with those of the systemic test, to establish the maximum rate, minimum, and average in groups according to the relationship of these two variables (Table 8, Figure 11). It was possible to determine, for this sample, below 50% (GR/GS×100) value on the retail test, indicating flap damage. Values above 60% indicated good quality of the flap, and those with values between 50 and 60% should be observed carefully.
Figure 1: Glucose flap per group versus time.
Figure 2: Systemic blood glucose level per group versus time.
Figure 3: Representation of the correlation between the Local and systemic test results in the exposed group and control, depending on the indicated time.
Figure 4: Flap length.
Figure 5: Flap width.
Figure 6. Flap and Pedicle dissection.
Figure 7: Flap harvested isolated only for the pedicle.
Figure 8: Systemic blood glucose measument form the rat tail.
Figure 9: Flap blood glucose measument from the edge of the flap.
Figure 10: Flap pedicle interrupted.
Figure 11: Representation of minimum and maximum values of the groups, control and exposed, for the percentage of Local glycemic test results correlating with the systemic blood glucose test results.
Tests of Normality |
||||||
Kolmogorov-Smirnova |
Shapiro-Wilk |
|||||
Statistic |
df |
Sig. |
Statistic |
df |
Sig. |
|
glic_ flap _0 |
0.121 |
20 |
0.200* |
0.945 |
20 |
0.293 |
gilc_sist_0 |
0.158 |
20 |
0.200* |
0.935 |
20 |
0.191 |
glic_ flap _30 |
0.12 |
20 |
0.200* |
0.967 |
20 |
0.684 |
gilc_sist_30 |
0.18 |
20 |
0.088 |
0.947 |
20 |
0.317 |
glic_ flap _60 |
0.111 |
20 |
0.200* |
0.947 |
20 |
0.318 |
gilc_sist_60 |
0.107 |
20 |
0.200* |
0.974 |
20 |
0.838 |
glic_ flap _90 |
0.117 |
20 |
0.200* |
0.952 |
20 |
0.396 |
gilc_sist_90 |
0.117 |
20 |
0.200* |
0.969 |
20 |
0.73 |
glic_ flap _120 |
0.118 |
20 |
0.200* |
0.936 |
20 |
0.202 |
gilc_sist_120 |
0.129 |
20 |
0.200* |
0.938 |
20 |
0.224 |
*. This is a lower bound of the true significance. |
||||||
a. Lilliefors Significance Correction |
Mean |
N |
Std. Deviation |
Std. Error Mean |
p |
||
Pair 1 |
glic_flap_0 |
147.85 |
20 |
42,450 |
9,492 |
0.095 |
glic_flap_120 |
187.75 |
20 |
83,449 |
18,660 |
||
Pair 2 |
gilc_sist_0 |
223.6 |
20 |
40,329 |
9,018 |
<0.0001 |
gilc_sist_120 |
349.55 |
20 |
84,357 |
18,863 |
Table 1: Representation of the normality test data.
Paired Samples Correlations |
||||
N |
Correlation |
Sig.=p |
||
Pair 1 |
glic_flap_0 & glic_flap _120 |
20 |
-0.217 |
0.359 |
Pair 2 |
gilc_sist_0 & gilc_sist_120 |
20 |
-0.25 |
0.287 |
Paired Samples Test |
|||||||||
Paired Differences |
t |
df |
Sig. (2-tailed) |
||||||
Mean |
Std. Deviation |
Std. Error Mean |
95% Confidence Interval of the Difference |
||||||
Lower |
Upper |
||||||||
Pair 1 |
glic_flap_0 - glic_flap_120 |
-39,900 |
1,01,496 |
22,695 |
-87,402 |
7,602 |
-1,758 |
19 |
0.095 |
Pair 2 |
gilc_sist_0 - gilc_sist_120 |
-1,25,950 |
1,02,198 |
22,852 |
-1,73,780 |
-78,120 |
-5,512 |
19 |
0 |
Table 2: Comparison between groups (control and exposed) depending on the times studied.
Paired Samples Statistics |
|||||||
Grupo |
Mean |
N |
Std. Deviation |
Std. Error Mean |
p |
||
Exposed |
Pair 1 |
glic_ flap _0 |
153.5 |
10 |
50,069 |
15,833 |
0.466 |
glic_flap_120 |
131.4 |
10 |
50,154 |
15,860 |
|||
Pair 2 |
gilc_sist_0 |
229.3 |
10 |
29,945 |
9,469 |
0.011 |
|
gilc_sist_120 |
346.6 |
10 |
98,747 |
31,226 |
|||
Control |
Pair 1 |
glic_ flap _0 |
142.2 |
10 |
35,020 |
11,074 |
0.001 |
glic_flap_120 |
244.1 |
10 |
71,622 |
22,649 |
|||
Pair 2 |
gilc_sist_0 |
217.9 |
10 |
49,646 |
15,700 |
0.001 |
|
gilc_sist_120 |
352.5 |
10 |
72,474 |
22,918 |
Table 3: Representation of test values, confidence interval, and variations.
Paired Samples Correlations |
|||||||||||||||
Grupo |
N |
Correlation |
Sig. |
||||||||||||
Exposed |
Pair 1 |
glic_ flap _0 & glic_ flap _120 |
10 |
-0.676 |
0.032 |
||||||||||
Pair 2 |
gilc_sist_0 & gilc_sist_120 |
10 |
-0.486 |
0.154 |
|||||||||||
Control |
Pair 1 |
glic_ flap _0 & glic_ flap _120 |
10 |
0.312 |
0.380 |
||||||||||
Pair 2 |
gilc_sist_0 & gilc_sist_120 |
10 |
-0.089 |
0.806 |
|||||||||||
Paired Samples Test |
|||||||||||||||
Grupo |
Paired Differences |
t |
df |
Sig. (2-tailed) |
|||||||||||
Mean |
Std. Deviation |
Std. Error Mean |
95% Confidence Interval of the Difference |
||||||||||||
Lower |
Upper |
||||||||||||||
Exposed |
Pair 1 |
glic_flap _0 - glic_flap_120 |
22,100 |
91,734 |
29,009 |
-43,523 |
87,723 |
.762 |
9 |
.466 |
|||||
Pair 2 |
gilc_sist_0 - gilc_sist_120 |
-1,17,300 |
1,16,294 |
36,775 |
-2,00,492 |
-34,108 |
-3,190 |
9 |
.011 |
||||||
Control |
Pair 1 |
glic_flap_0 - glic_flap _120 |
-1,01,900 |
69,211 |
21,886 |
-1,51,410 |
-52,390 |
-4,656 |
9 |
.001 |
|||||
Pair 2 |
gilc_sist_0 - gilc_sist_120 |
-1,34,600 |
91,427 |
28,912 |
-2,00,003 |
-69,197 |
-4,656 |
9 |
.001 |
||||||
Table 4: Analysis of paired data between systemic blood glucose value and Local blood glucose test results of the exposed groups at the evaluated times.
Mean blood glucose values by time and group
Flap Glycemia |
Systemic Glycemia |
|||||||||
Time |
||||||||||
Group |
0 |
30 |
60 |
90 |
120 |
0 |
30 |
60 |
90 |
120 |
Exposed |
153.5 |
135.5 |
132.3 |
119.1 |
131.4 |
229.3 |
286.1 |
337.5 |
322.1 |
346.6 |
Control |
142.2 |
192.8 |
223.4 |
241.3 |
244.1 |
217.9 |
280.4 |
304.3 |
329.2 |
352.5 |
Table 5: Analysis of the correlation between systemic value and Local test results of exposed groups at the evaluated times by Pearson index.
Group Statistics |
|||||||||
Grupo |
Mean |
Std. Deviation |
Std. Error Mean |
p |
|||||
glic_flap_0 |
Exposed |
153.5 |
50,069 |
15,833 |
0.566 |
||||
Control |
142.2 |
35,020 |
11,074 |
||||||
gilc_sist_0 |
Exposed |
229.3 |
29,945 |
9,469 |
0.542 |
||||
Control |
217.9 |
49,646 |
15,700 |
||||||
glic_flap_30 |
Exposed |
135.5 |
52,926 |
16,737 |
0.01 |
||||
Control |
192.8 |
34,915 |
11,041 |
||||||
gilc_sist_30 |
Exposed |
286.1 |
41,565 |
13,144 |
0.783 |
||||
Control |
280.4 |
49,151 |
15,543 |
||||||
glic_flap_60 |
Exposed |
132.3 |
45,911 |
14,518 |
0.002 |
||||
Control |
223.4 |
61,965 |
19,595 |
||||||
gilc_sist_60 |
Exposed |
337.5 |
62,477 |
19,757 |
0.272 |
||||
Control |
304.3 |
68,302 |
21,599 |
||||||
glic_flap_90 |
Exposed |
119.1 |
36,336 |
11,491 |
<0.0001 |
||||
Control |
241.3 |
56,671 |
17,921 |
||||||
gilc_sist_90 |
Exposed |
322.1 |
63,897 |
20,206 |
0.811 |
||||
Control |
329.2 |
66,824 |
21,132 |
||||||
glic_flap_120 |
Exposed |
131.4 |
50,154 |
15,860 |
0.001 |
||||
Control |
244.1 |
71,622 |
22,649 |
||||||
gilc_sist_120 |
Exposed |
346.6 |
98,747 |
31,226 |
0.881 |
||||
Control |
352.5 |
72,474 |
22,918 |
||||||
df |
Sig. (2-tailed) |
Mean Difference |
Std. Error Difference |
95% Confidence Interval of the Difference |
|||||
Lower |
Upper |
||||||||
18 |
0.566 |
11,300 |
19,322 |
-29,294 |
51,894 |
||||
18 |
0.542 |
11,400 |
18,334 |
-27,119 |
49,919 |
||||
18 |
0.01 |
-57,300 |
20,051 |
-99,425 |
-15,175 |
||||
18 |
0.783 |
5,700 |
20,356 |
-37,065 |
48,465 |
||||
18 |
0.002 |
-91,100 |
24,387 |
-142.33 |
-39,864 |
||||
18 |
0.272 |
33,200 |
29,272 |
-28,298 |
94,698 |
||||
18 |
0 |
-122.2 |
21,288 |
-166.92 |
-77,475 |
||||
18 |
0.811 |
-7,100 |
29,237 |
-68,526 |
54,326 |
||||
18 |
0.001 |
-112.7 |
27,650 |
-170.79 |
-54,610 |
||||
18 |
0.881 |
-5,900 |
38,734 |
-87,278 |
75,478 |
||||
Table 6: Analysis of paired data between systemic blood glucose value and Local test results of the control group at the evaluated times.
Correlations (n=20) |
|||||||||||
glic_ flap _0 |
gilc_sist_0 |
glic_ flap _30 |
gilc_sist_30 |
glic_flap_60 |
gilc_sist_60 |
glic_flap_90 |
gilc_sist_90 |
glic_flap_120 |
gilc_sist_120 |
||
glic_flap_0 |
Pearson Correlation |
1 |
0.151 |
0.335 |
.465* |
0.054 |
-0.263 |
-0.224 |
-0.104 |
-0.217 |
0.095 |
Sig. (2-tailed) |
0.525 |
0.148 |
0.039 |
0.821 |
0.262 |
0.343 |
0.662 |
0.359 |
0.689 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
gilc_sist_0 |
Pearson Correlation |
0.151 |
1 |
0.045 |
0.146 |
0.063 |
0.232 |
-0.014 |
-0.128 |
0.108 |
-0.25 |
Sig. (2-tailed) |
0.525 |
0.85 |
0.538 |
0.792 |
0.324 |
0.952 |
0.591 |
0.651 |
0.287 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
glic_ flap _30 |
Pearson Correlation |
0.335 |
0.045 |
1 |
0.185 |
.527* |
-0.145 |
.474* |
0.096 |
0.289 |
-0.042 |
Sig. (2-tailed) |
0.148 |
0.85 |
0.434 |
0.017 |
0.543 |
0.035 |
0.686 |
0.217 |
0.861 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
gilc_sist_30 |
Pearson Correlation |
.465* |
0.146 |
0.185 |
1 |
0.013 |
-0.107 |
-0.051 |
-0.248 |
-0.013 |
0.043 |
Sig. (2-tailed) |
0.039 |
0.538 |
0.434 |
0.956 |
0.654 |
0.83 |
0.291 |
0.955 |
0.857 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
glic_ flap _60 |
Pearson Correlation |
0.054 |
0.063 |
.527* |
0.013 |
1 |
0.273 |
.732** |
.468* |
.735** |
0.073 |
Sig. (2-tailed) |
0.821 |
0.792 |
0.017 |
0.956 |
0.244 |
0 |
0.037 |
0 |
0.761 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
gilc_sist_60 |
Pearson Correlation |
-0.263 |
0.232 |
-0.145 |
-0.107 |
0.273 |
1 |
0.093 |
.615** |
0.252 |
0.049 |
Sig. (2-tailed) |
0.262 |
0.324 |
0.543 |
0.654 |
0.244 |
0.695 |
0.004 |
0.284 |
0.837 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
glic_ flap _90 |
Pearson Correlation |
-0.224 |
-0.014 |
.474* |
-0.051 |
.732** |
0.093 |
1 |
.472* |
.834** |
-0.084 |
Sig. (2-tailed) |
0.343 |
0.952 |
0.035 |
0.83 |
0 |
0.695 |
0.035 |
0 |
0.726 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
gilc_sist_90 |
Pearson Correlation |
-0.104 |
-0.128 |
0.096 |
-0.248 |
.468* |
.615** |
.472* |
1 |
0.378 |
0.127 |
Sig. (2-tailed) |
0.662 |
0.591 |
0.686 |
0.291 |
0.037 |
0.004 |
0.035 |
0.101 |
0.595 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
glic_ flap _120 |
Pearson Correlation |
-0.217 |
0.108 |
0.289 |
-0.013 |
.735** |
0.252 |
.834** |
0.378 |
1 |
-0.01 |
Sig. (2-tailed) |
0.359 |
0.651 |
0.217 |
0.955 |
0 |
0.284 |
0 |
0.101 |
0.966 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
gilc_sist_120 |
Pearson Correlation |
0.095 |
-0.25 |
-0.042 |
0.043 |
0.073 |
0.049 |
-0.084 |
0.127 |
-0.01 |
1 |
Sig. (2-tailed) |
0.689 |
0.287 |
0.861 |
0.857 |
0.761 |
0.837 |
0.726 |
0.595 |
0.966 |
||
N |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
|
Table 7: Correlation analysis by Pearson index between systemic and Local blood glucose of control groups at the evaluated times.
Correlations |
||||||||
Grupo |
glic_ret_0 |
gilc_sist_0 |
||||||
Exposed |
Pearson Correlation |
glic_ flap _0 |
1,000 |
0.039 |
||||
gilc_sist_0 |
0.039 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _0 |
. |
0.457 |
|||||
gilc_sist_0 |
0.457 |
. |
||||||
N |
glic_ flap _0 |
10 |
10 |
|||||
gilc_sist_0 |
10 |
10 |
||||||
Control |
Pearson Correlation |
glic_ flap _0 |
1,000 |
0.239 |
||||
gilc_sist_0 |
0.239 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _0 |
. |
0.253 |
|||||
gilc_sist_0 |
0.253 |
. |
||||||
N |
glic_ flap _0 |
10 |
10 |
|||||
gilc_sist_0 |
10 |
10 |
||||||
Correlations |
||||||||
Group |
glic_ret_30 |
gilc_sist_30 |
||||||
Exposed |
Pearson Correlation |
glic_ flap _30 |
1,000 |
0.602 |
||||
gilc_sist_30 |
0.602 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _30 |
. |
0.033 |
|||||
gilc_sist_30 |
0.033 |
. |
||||||
N |
glic_ flap _30 |
10 |
10 |
|||||
gilc_sist_30 |
10 |
10 |
||||||
Controle |
Pearson Correlation |
glic_ flap _30 |
1,000 |
-0.134 |
||||
gilc_sist_30 |
-0.134 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _30 |
. |
0.356 |
|||||
gilc_sist_30 |
0.356 |
. |
||||||
N |
glic_ flap _30 |
10 |
10 |
|||||
gilc_sist_30 |
10 |
10 |
||||||
Correlations |
||||||||
Group |
glic_ret_60 |
gilc_sist_60 |
||||||
Exposed |
Pearson Correlation |
glic_ flap _60 |
1,000 |
0.543 |
||||
gilc_sist_60 |
0.543 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _60 |
. |
0.052 |
|||||
gilc_sist_60 |
0.052 |
. |
||||||
N |
glic_ flap _60 |
10 |
10 |
|||||
gilc_sist_60 |
10 |
10 |
||||||
Control |
Pearson Correlation |
glic_ flap _60 |
1,000 |
0.664 |
||||
gilc_sist_60 |
0.664 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _60 |
. |
0.018 |
|||||
gilc_sist_60 |
0.018 |
. |
||||||
N |
glic_ flap _60 |
10 |
10 |
|||||
gilc_sist_60 |
10 |
10 |
||||||
Correlations |
||||||||
Group |
glic_ret_90 |
gilc_sist_90 |
||||||
Exposed |
Pearson Correlation |
glic_ flap _90 |
1,000 |
0.582 |
||||
gilc_sist_90 |
0.582 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _90 |
. |
0.039 |
|||||
gilc_sist_90 |
0.039 |
. |
||||||
N |
glic_ flap _90 |
10 |
10 |
|||||
gilc_sist_90 |
10 |
10 |
||||||
Control |
Pearson Correlation |
glic_ flap _90 |
1,000 |
0.824 |
||||
gilc_sist_90 |
0.824 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _90 |
. |
0.002 |
|||||
gilc_sist_90 |
0.002 |
. |
||||||
N |
glic_ flap _90 |
10 |
10 |
|||||
gilc_sist_90 |
10 |
10 |
||||||
Correlations |
||||||||
Group |
glic_ret_120 |
gilc_sist_120 |
||||||
Exposed |
Pearson Correlation |
glic_ flap _120 |
1,000 |
0.193 |
||||
gilc_sist_120 |
0.193 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _120 |
. |
0.297 |
|||||
gilc_sist_120 |
0.297 |
. |
||||||
N |
glic_ flap _120 |
10 |
10 |
|||||
gilc_sist_120 |
10 |
10 |
||||||
Control |
Pearson Correlation |
glic_ flap _120 |
1,000 |
-0.284 |
||||
gilc_sist_120 |
-0.284 |
1,000 |
||||||
Sig. (1-tailed) |
glic_ flap _120 |
. |
0.213 |
|||||
gilc_sist_120 |
0.213 |
. |
||||||
N |
glic_ flap _120 |
10 |
10 |
|||||
gilc_sist_120 |
10 |
10 |
||||||
Table 8: Representative percentage of the glucose ratio of the Local test in relationship to the systemic test (GR/GS x100).
Discussion
Monitoring flaps has a fundamental role in the success of the surgery, in case of a new approach. Parameters such as color, turgor and perfusion, and temperature measurements by thermal diffusion poor can suggest flap distress. Considering the blood glucose as a parameter evaluation, we can detect possible failure earlier. Systemic blood glucose level presents variations throughout the day and throughout a surgical procedure. Likewise, the values found in the flaps may also be subject to the same variations. Studies have been conducted to determine the values on retail tests to be considered to indicate distress. Sitzman in 2010, using the retail test on vertical abdominal flaps in rats, studied the decrease in blood glucose level in flaps because of occlusion of both the arterial and venous system, and compared the values obtained for the same flap in contralateral operated rats. Assuming sensitivity and specificity of 100%, a decrease in blood glucose value ≥ 7 mg/dL/min or decreased blood glucose values ≥ 2 mg/dL/min was associated with the level < 118 mg/dL [12].Assessing the decrease in glucose level in the work by Sitzman, we realized that the curve follows a pattern similar to the flap glycemic index. Hjortdal 1991 and Cohen 1983 noted that Local test blood glucose values decreased, returning to normal values by the seventh day [16,17]. Hara in 2012, evaluating data from 33 free flaps in humans, found the absolute value of 62 mg/dL as the cutoff value from the ROC curve, determining a sensitivity of 88% and specificity of 82% for flap damage [15].
In this study comparing the blood glucose measurements in the flap and systemic determination of the flap glycemic index, our results suggest that monitoring can be performed in a comparative way, besides using the absolute measure. The results we found show that both viable flaps and those in distress have similar measures at time 0. However, after 30 minutes, the experimental group showed values indicating distress, which was also evident in the following times. Another interesting point was to establish an interval in which to observe the flap, where less than 50% value indicates distress, between 50 and 60% value should be carefully observed, and a value >60% indicates the flap has good indications for success, contrary to an absolute cutoff value, as indicated by Hara et al. The values found in this study may not match those of other species, despite being the model most frequently used, because of its resemblance to the human model, because our index were glucose levels relative to the percentages of retail test/glucose systemic test values, which can be a very interesting parameter to be studied in daily practice.
Conclusion
FGI may be used as a postoperative assessment tool to determine flap distress during an early stage in experimental models. In addition, it might be useful in clinical practice, but its specificity needs to be confirmed in humans as well.
References
- Bui DT, Cordeiro PG, Hu QY, Disa JJ, Pusic A, et al. (2007) Free flap reexploration: Indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 119: 2092-2100.
- Kroll SS, Schusterman MA, Reece GP (1996) Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg 98: 1230-1233.
- Seres L, Makula E, Morvay Z, Borbely L (2002) Color Doppler ultrasound for monitoring free flaps in the head and neck region. J Craniofac Surg 13: 75e8.
- Few JW, Corral CJ, Fine NA, Dumanian GA (2001) Monitoring buried head and neck free flaps with high-resolution color duplex ultrasound. Plast Reconstr Surg 108: 709e12.
- Schon R, Schramm A, Gellrich NC, Maier W, Duker J, et al. (2003) Color duplex sonography for the monitoring of vascularized free bone flaps. Otolaryngol Head Neck Surg 129: 71e6.
- Delgado JM, DeFeudis FV, Roth RH, Ryugo DK, Mitruka BM (1972) Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther 198: 9e21.
- Nord AE, Rojdmark J, Wickman M (2002) Metabolism in pedicled and free TRAM flaps: a comparison using the microdialysis technique. Plast Reconstr 109: 664e73.
- Rojdmark J, Blomqvist L, Malm M, Adams-Ray B, Ungerstedt U (1998) Metabolism in myocutaneous flaps studied by in situ microdialysis. Scand J Plast Reconstr Surg Hand Surg 32: 27e34.
- Khot MB, Maitz PK, Phillips BR, Bowman HF, Pribaz JJ, et al. (2005) Thermal diffusion probe analysis of perfusion changes in vascular occlusions of rabbit pedicle flaps. Plast Reconstr Surg 115: 1103-1109.
- Hjortdal VE, Kjølseth D, Henriksen TB, Hansen ES, Møller N (1991) Fuel metabolism in a pig myocutaneous island flap model. Plast Reconstr Surg 88: 664-672.
- Sitzman TJ, Hanson SE, King TW, Gutowski KA (2010) Detection of Flap Venous and Arterial Occlusion Using Interstitial Glucose Monitoring in a Rodent Model. Plast Reconstr Surg 126: 71-79.
- Setälä LP, Korvenoja EM, Härmä MA, Alhava EM, Uusaro AV, et al. (2004) Glucose, lactate, and pyruvate response in an experimental model of microvascular flap ischemia and reperfusion. Microsurgery 24: 223e31.
- Su CT, Im MJ, Hoopes JE (1982) Tissue glucose and lactate following vascular occlusion in island skin flaps. Plast Reconstr Surg 70: 202205.
- Liao EC, Taghinia AH, Nguyen LP, Yueh JH, May JW, et al. (2008) Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg 121: 1101-1107.
- Hisako Hara, Makoto Mihara, Takuya Iida, Mitsunaga Narushima, Isao Koshima (2012) Blood glucose measurement in flap monitoring for salvage of flaps from venous thrombosis. Plast Reconstr Surg 129(3):587e-589e.
- Cohen BE, Harmon CS, Phizackerley PJ (1983) Glucose metabolism in experimental skin flaps. Plast Reconstr Surg 71: 79-86.
- Im MJ, Su CT, Hoopes JE (1979) Metabolic adaptations in delayed skin flaps. Glucose utilization and hexokinase activity. Plast Reconstr Surg 64: 244-248.
© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. Read More About Open Access Policy.